Docstoc

Combined position of DOG and BVA on photodynamic therapy

Document Sample
Combined position of DOG and BVA on photodynamic therapy Powered By Docstoc
					2000

[Combined position of DOG and BVA on photodynamic therapy]. Klin Monatsbl Augenheilkd 216 (3): 127-128, 2000

[Senile macular degeneration. Photodynamic therapy stabilizes vision]. MMW Fortschr Med 142 (35): 46-47, 2000

Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2001. Health Care Financing
Administration (HCFA), HHS. Final rule with comment period. Fed Regist 65 (212): 65376-65603, 2000

New treatment for actinic keratosis.   Harv Womens Health Watch 7 (9): 6, 2000

Photodynamic therapy for subfoveal choroidal neovascularization. Tecnologica MAP Suppl : 21-25, 2000

Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology. Ophthalmology
107 (12): 2314-2317, 2000

Photodynamic therapy with verteporfin (Visudyne) for macular degeneration. Med Lett Drugs Ther 42 (1086): 81-82, 2000

Ackermann G; Abels C; Karrer S; Baumler W; Landthaler M; Szeimies RM. [Fluorescence-assisted biopsy of basal cell carcinomas].
Hautarzt 51 (12): 920-924, 2000

Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Stoddard CJ; Reed MW. Aminolevulinic acid-induced photodynamic therapy: safe
and effective ablation of dysplasia in Barrett's esophagus. Dis Esophagus 13 (1): 18-22, 2000

Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Marcus SL; Stoddard CJ; Johnson AG; Reed MW. Photodynamic therapy for
dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 47 (5): 612-617, 2000

Agostinis P; Assefa Z; Vantieghem A; Vandenheede JR; Merlevede W; de Witte P. Apoptotic and anti-apoptotic signaling pathways
induced by photodynamic therapy with hypericin. Adv Enzyme Regul 40: 157-182, 2000

Ahmad N; Gupta S; Feyes DK; Mukhtar H. Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in
human epidermoid carcinoma A431 cells. J Invest Dermatol 115 (6): 1041-1046, 2000

Ahmad N; Mukhtar H. Mechanism of photodynamic therapy-induced cell death. Methods Enzymol 319: 342-358, 2000

Aksenova AA; Sebiakin I; Mironov AF. [The synthesis of galactopyranosyl-substituted derivatives of pheophorbide].    Bioorg Khim 26
(2): 126-129, 2000

Al'-Shukri SK; Danil'chenko DI; Kenig F; Shnorr D. [ALA fluorescent diagnosis of bladder cancer].    Urologiia (5): 48-50, 2000

Ali I; Gatasheh MK; Naseem I. Hemolysis of human red blood cells by riboflavin-Cu(II) system. Biochim Biophys Acta 1523 (2-3):
225-229, 2000

Allman R; Cowburn P; Mason M. Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell
carcinoma cell lines of the head and neck. Br J Cancer 83 (5): 655-661, 2000

Andrejevic BS; Ballini JP; van den BH; Fontolliet C; Wagnieres G; Monnier P. Time-dependent biodistribution of tetra(m-
hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy
study. Photochem Photobiol 71 (3): 333-340, 2000

Ashikaga T; Wada M; Kobayashi H; Mori M; Katsumura Y; Fukui H; Kato S; Yamaguchi M; Takamatsu T. Effect of the photocatalytic
activity of TiO(2) on plasmid DNA. Mutat Res 466 (1): 1-7, 2000

Augustin AJ. [Photodynamic therapy with Vsudyne (Verteporfin)--an innovative therapy of age-related macular degeneration].
Krankenpfl J 38 (9-10): 342-343, 2000

Aurora R; Milite F; Vander Els NJ. Respiratory emergencies.    Semin Oncol 27 (3): 256-269, 2000

Babbar AK; Singh AK; Goel HC; Chauhan UP; Sharma RK. Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative,
as a potential radiopharmaceutical for tumor scintigraphy. Nucl Med Biol 27 (6): 587-592, 2000

Babincova M; Sourivong P; Babinec P. Gene transfer-mediated intracellular photodynamic therapy. Med Hypotheses 54 (2): 180-181,
2000

Balasubramanian D. Ultraviolet radiation and cataract.   J Ocul Pharmacol Ther 16 (3): 285-297, 2000
Banerjee A; George J. Bronchoscopic photodynamic diagnosis and therapy for lung cancer.      Curr Opin Pulm Med 6 (4): 378-383,
2000

Barbazetto I; Schmidt-Erfurth U. Photodynamic therapy of choroidal hemangioma: two case reports.      Graefes Arch Clin Exp
Ophthalmol 238 (3): 214-221, 2000

Barbezat GO. New treatment for Barrett's oesophagus. Biomed Pharmacother 54 (7): 362-367, 2000

Barr H. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. Gastrointest Endosc Clin N Am 10 (3):
421-437, 2000

Barr H. Photodynamic therapy in gastrointestinal cancer: a realistic option?   Drugs Aging 16 (2): 81-86, 2000

Bartosova J; Hrkal Z. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid
(ALA). Comp Biochem Physiol C Toxicol Pharmacol 126 (3): 245-252, 2000

Bazin M; Bosca F; Marin ML; Miranda MA; Patterson LK; Santus R. A laser flash photolysis and pulse radiolysis study of primary
photochemical processes of flumequine. Photochem Photobiol 72 (4): 451-457, 2000

Becker MD; Rosenbaum JT. Current and future trends in the use of immunosuppressive agents in patients with uveitis.     Curr Opin
Ophthalmol 11 (6): 472-477, 2000

Belickova M; Bruchova H; Cajthamlova H; Hrkal Z; Brdicka R. Genes involved in the destruction of leukaemic cells by induced
photosensitivity. Folia Biol (Praha) 46 (4): 131-135, 2000

Belmont MJ; Marabelle N; Mang TS; Hall R; Wax MK. Effect of photodynamic therapy on revascularization of fasciocutaneous flaps.
Laryngoscope 110 (6): 942-945, 2000

Berger Y; Greppi A; Siri O; Neier R; Juillerat-Jeanneret L. Ethylene glycol and amino acid derivatives of 5-aminolevulinic acid as new
photosensitizing precursors of protoporphyrin IX in cells. J Med Chem 43 (25): 4738-4746, 2000

Berr F; Tannapfel A; Lamesch P; Pahernik S; Wiedmann M; Halm U; Goetz AE; Mossner J; Hauss J. Neoadjuvant photodynamic
therapy before curative resection of proximal bile duct carcinoma. J Hepatol 32 (2): 352-357, 2000

Berr F; Wiedmann M; Tannapfel A; Halm U; Kohlhaw KR; Schmidt F; Wittekind C; Hauss J; Mossner J. Photodynamic therapy for
advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31 (2): 291-298, 2000

Bertoloni G; Lauro FM; Cortella G; Merchat M. Photosensitizing activity of hematoporphyrin on Staphylococcus aureus cells. Biochim
Biophys Acta 1475 (2): 169-174, 2000

Biasutti MA; Soltermann AT; Garcia NA. Photodynamic effect in lysozyme: a kinetic study in different micellar media.     J Pept Res 55
(1): 41-50, 2000

Bisby RH; Mead C; Morgan CG. Active uptake of drugs into photosensitive liposomes and rapid release on UV photolysis.       Photochem
Photobiol 72 (1): 57-61, 2000

Bissonnette R; Shapiro J; Zeng H; McLean DI; Lui H. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair
regrowth in patients with extensive alopecia areata. Br J Dermatol 143 (5): 1032-1035, 2000

Bistolfi F. Red radioluminescence and radiochemiluminescence: premises for a photodynamic tumour therapy with X-rays and
haematoporphyrin derivatives. A working hypothesis. Panminerva Med 42 (1): 69-75, 2000

Blank M; Lavie G; Mandel M; Keisari Y. Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors.
Oncol Res 12 (9-10): 409-418, 2000

Blumenkranz MS; Woodburn KW; Qing F; Verdooner S; Kessel D; Miller R. Lutetium texaphyrin (Lu-Tex): a potential new agent for
ocular fundus angiography and photodynamic therapy. Am J Ophthalmol 129 (3): 353-362, 2000

Bocking T; Barrow KD; Netting AG; Chilcott TC; Coster HG; Hofer M. Effects of singlet oxygen on membrane sterols in the yeast
Saccharomyces cerevisiae. Eur J Biochem 267 (6): 1607-1618, 2000

Boehncke WH; Elshorst-Schmidt T; Kaufmann R. Systemic photodynamic therapy is a safe and effective treatment for psoriasis.       Arch
Dermatol 136 (2): 271-272, 2000


2
Bossu E; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F. Determination of the maximal carcinoma/normal skin ratio after HpD or
m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy. Anticancer Drugs 11 (2): 85-91, 2000

Bourdon O; Mosqueira V; Legrand P; Blais J. A comparative study of the cellular uptake, localization and phototoxicity of meta-
tetra(hydroxyphenyl) chlorin encapsulated in surface-modified submicronic oil/water carriers in HT29 tumor cells. J Photochem
Photobiol B 55 (2-3): 164-171, 2000

Bown SG. Photodynamic therapy. Hosp Med 61 (4): 289, 2000

Bown SG; Lovat LB. The biology of photodynamic therapy in the gastrointestinal tract.    Gastrointest Endosc Clin N Am 10 (3): 533-
550, 2000

Brasseur N; Menard I; Forget A; el Jastimi R; Hamel R; Molfino NA; van Lier JE. Eradication of multiple myeloma and breast cancer
cells by TH9402-mediated photodynamic therapy: implication for clinical ex vivo purging of autologous stem cell transplants.
Photochem Photobiol 72 (6): 780-787, 2000

Bressler NM. Age related macular degeneration. New hope for a common problem comes from photodynamic therapy.           BMJ 321
(7274): 1425-1427, 2000

Bressler NM; Bressler SB. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.       Invest
Ophthalmol Vis Sci 41 (3): 624-628, 2000

Brundish DE; Love WG. Photodynamic therapy comes of age. IDrugs 3 (12): 1487-1508, 2000

Bryce R. Burns after photodynamic therapy. Drug point gives misleading impression of incidence of burns with temoporfin (Foscan).
BMJ 320 (7251): 1731-1732, 2000

Bucking M; Gudgin Dickson EF; Farahani M; Fischer F; Holmes D; Jori G; Kennedy JC; Kenney ME; Peng X; Pottier RH; Weagle G.
Quantification of the selective retention of palladium octabutoxynaphthalocyanine, a potential photothermal drug, in mouse tissues. J
Photochem Photobiol B 58 (2-3): 87-93, 2000

Bunke A; Zerbe O; Schmid H; Burmeister G; Merkle HP; Gander B. Degradation mechanism and stability of 5-aminolevulinic acid.            J
Pharm Sci 89 (10): 1335-1341, 2000

Bunse A; Elsner H; Laqua H; Schmidt-Erfurth U. [Micro-perimetric documentation of retinal function in photodynamic therapy of
choroid neovascularizations]. Klin Monatsbl Augenheilkd 216 (3): 158-164, 2000

Burdick JS; Magee D; Miller G; Wright KB. Biliary photodynamic therapy alternative delivery technique.      Endoscopy 32 (10): S63,
2000

Busch TM; Hahn SM; Evans SM; Koch CJ. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia
marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ]. Cancer Res 60 (10): 2636-2642, 2000

Canete M; Ortiz A; Juarranz A; Villanueva A; Nonell S; Borrell JI; Teixido J; Stockert JC. Photosensitizing properties of palladium-
tetraphenylporphycene on cultured tumour cells. Anticancer Drug Des 15 (2): 143-150, 2000

Casas A; Fukuda H; Di Venosa G; Batlle AM. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-
aminolaevulinic acid. Implications in cutaneous photodynamic sensitization. Br J Dermatol 143 (3): 564-572, 2000

Ceburkov O; Gollnick H. Photodynamic therapy in dermatology. Eur J Dermatol 10 (7): 568-575, 2000

Chan WH; Yu JS; Yang SD. Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: involvement of
singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2. Biochem J 351 (Pt 1): 221-232, 2000

Chang S; Chern I; Bown SG. Photodynamic therapy of rat bladder and urethra: evaluation of urinary and reproductive function after
inducing protoporphyrin IX with 5-aminolaevulinic acid. BJU Int 85 (6): 747-753, 2000

Chen B; de Witte PA. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.
Cancer Lett 150 (1): 111-117, 2000

Chen JY; Cheung NH; Fung MC; Wen JM; Leung WN; Mak NK. Subcellular localization of merocyanine 540 (MC540) and induction
of apoptosis in murine myeloid leukemia cells. Photochem Photobiol 72 (1): 114-120, 2000


3
Chen JY; Mak NK; Yow CM; Fung MC; Chiu LC; Leung WN; Cheung NH. The binding characteristics and intracellular localization of
temoporfin (mTHPC) in myeloid leukemia cells: phototoxicity and mitochondrial damage. Photochem Photobiol 72 (4): 541-547,
2000

Cheng CW; Lau WK; Tan PH; Olivo M. Cystoscopic diagnosis of bladder cancer by intravesical instillation of 5-aminolevulinic acid
induced porphyrin fluorescence--the Singapore experience. Ann Acad Med Singapore 29 (2): 153-158, 2000

Chiu SM; Davis TW; Meyers M; Ahmad N; Mukhtar H; Separovic D. Phthalocyanine 4-photodynamic therapy induces ceramide
generation and apoptosis in acid sphingomyelinase-deficient mouse embryonic fibroblasts. Int J Oncol 16 (2): 423-427, 2000

Chmielowiec U; Kwasny M. Determination of 5-aminolevulinic acid (ALA) by HPLC method. Acta Pol Pharm 57 Suppl: 149-150,
2000

Christensen NR; Charabi S; Johansen LS; Rygaard J; Balle VH; Tos M; Thomsen J. Effect of photodynamic therapy on a
heterotransplanted human parotid tumor. Auris Nasus Larynx 27 (3): 241-245, 2000

Chung PS; Rhee CK; Kim KH; Paek W; Chung J; Paiva MB; Eshraghi AA; Castro DJ; Saxton RE. Intratumoral hypericin and KTP laser
therapy for transplanted squamous cell carcinoma. Laryngoscope 110 (8): 1312-1316, 2000

Chung WY; Lee JM; Lee WY; Surh YJ; Park KK. Protective effects of hemin and tetrakis(4-benzoic acid)porphyrin on bacterial
mutagenesis and mouse skin carcinogenesis induced by 7, 12-dimethylbenz[a]anthracene. Mutat Res 472 (1-2): 139-145, 2000

Colasanti A; Kisslinger A; Liuzzi R; Quarto M; Riccio P; Roberti G; Tramontano D; Villani F. Hypericin photosensitization of tumor
and metastatic cell lines of human prostate. J Photochem Photobiol B 54 (2-3): 103-107, 2000

Corti L; Skarlatos J; Boso C; Cardin F; Kosma L; Koukourakis MI; Giatromanolaki A; Norberto L; Shaffer M; Beroukas K. Outcome of
patients receiving photodynamic therapy for early esophageal cancer. Int J Radiat Oncol Biol Phys 47 (2): 419-424, 2000

Cosserat-Gerardin I; Bezdetnaya L; Notter D; Vigneron C; Guillemin F. Biosynthesis and photodynamic efficacy of protoporphyrin IX
(PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells. J Photochem Photobiol B
59 (1-3): 72-79, 2000

Cubeddu R; Pifferi A; Taroni P; Torricelli A; Valentini G; Comelli D; D'Andrea C; Angelini V; Canti G. Fluorescence imaging during
photodynamic therapy of experimental tumors in mice sensitized with disulfonated aluminum phthalocyanine. Photochem Photobiol
72 (5): 690-695, 2000

Cui ZJ; Habara Y; Satoh Y. Photodynamic modulation of adrenergic receptors in the isolated rat hepatocytes.    Biochem Biophys Res
Commun 277 (3): 705-710, 2000

Curnow A; Haller JC; Bown SG. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon.
Comparison of continuous and fractionated light regimes. J Photochem Photobiol B 58 (2-3): 149-155, 2000

Dahle J; Mikalsen SO; Rivedal E; Steen HB. Gap junctional intercellular communication is not a major mediator in the bystander effect
in photodynamic treatment of MDCK II cells. Radiat Res 154 (3): 331-341, 2000

Dahle J; Bagdonas S; Kaalhus O; Olsen G; Steen HB; Moan J. The bystander effect in photodynamic inactivation of cells.    Biochim
Biophys Acta 1475 (3): 273-280, 2000

Danilatou V; Lydaki E; Dimitriou H; Papazoglou T; Kalmanti M. Bone marrow purging by photodynamic treatment in children with
acute leukemia: cytoprotective action of amifostine. Leuk Res 24 (5): 427-435, 2000

Danis RP; Wolverton S; Steffens T. Phototoxicity from systemic sodium fluorescein.     Retina 20 (4): 370-373, 2000

De Rosa FS; Marchetti JM; Thomazini JA; Tedesco AC; Bentley MV. A vehicle for photodynamic therapy of skin cancer: influence of
dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by
confocal microscopy. J Control Release 65 (3): 359-366, 2000

De Rosa FS; Bentley MV. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.   Pharm Res 17
(12): 1447-1455, 2000

Del Governatore M; Hamblin MR; Shea CR; Rizvi I; Molpus KG; Tanabe KK; Hasan T. Experimental photoimmunotherapy of hepatic
metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res 60 (15): 4200-4205, 2000


4
Delaey E; van Laar F; De Vos D; Kamuhabwa A; Jacobs P; de Witte P. A comparative study of the photosensitizing characteristics of
some cyanine dyes. J Photochem Photobiol B 55 (1): 27-36, 2000

Delaey E; Vandenbogaerde A; Merlevede W; de Witte P. Photocytotoxicity of hypericin in normoxic and hypoxic conditions.       J
Photochem Photobiol B 56 (1): 19-24, 2000

Dent NJ. Is ICH exportable outside the European Union? Qual Assur 8 (1): 19-31, 2000

Devereaux CE; Binmoeller KF. Endoscopic retrograde cholangiopancreatography in the next millennium.       Gastrointest Endosc Clin N
Am 10 (1): 117-33, vii, 2000

Dima VF; Ionescu MD. Ultrastructural changes induced in Walker carcinosarcoma by treatment with dihematoporphyrin ester and light
in animals with diabetes mellitus. Roum Arch Microbiol Immunol 59 (1-2): 119-130, 2000

Douplik A; Stratonnikov AA; Loshchenov VB; Lebedeva VS; Derkacheva VM; Vitkin A; Rumyanceva VD; Kusmin SG; Mironov AF;
Luk'yanets EA. Study of photodynamic reactions in human blood. J Biomed Opt 5 (3): 338-349, 2000

Dow RJ. Burns after photodynamic therapy: manufacturer's response to second authors' reply. BMJ 321 (7252): 53, 2000

Dubessy C; Merlin JM; Marchal C; Guillemin F. Spheroids in radiobiology and photodynamic therapy.       Crit Rev Oncol Hematol 36
(2-3): 179-192, 2000

Dwyer PJ; White WM; Fabian RL; Anderson RR. Optical integrating balloon device for photodynamic therapy.        Lasers Surg Med 26
(1): 58-66, 2000

Eichler J; Liebetruth J; London RA; Ziegenhagen L. Temperature distribution for combined laser hyperthermia-photodynamic therapy in
the esophagus. Med Eng Phys 22 (4): 307-312, 2000

El Missiry MA; Abou-Seif M. Photosensitization induced reactive oxygen species and oxidative damage in human erythrocytes.
Cancer Lett 158 (2): 155-163, 2000

Eleouet S; Rousset N; Carre J; Vonarx V; Vilatte C; Louet C; Lajat Y; Patrice T. Heterogeneity of delta-aminolevulinic acid-induced
protoporphyrin IX fluorescence in human glioma cells and leukemic lymphocytes. Neurol Res 22 (4): 361-368, 2000

Eleouet S; Rousset N; Carre J; Bourre L; Vonarx V; Lajat Y; Beijersbergen Van Henegouwen GM; Patrice T. In vitro fluorescence,
toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem Photobiol 71 (4): 447-454, 2000

Ell C; Gossner L. Photodynamic therapy. Recent Results Cancer Res 155: 175-181, 2000

Endo C; Sagawa M; Sato M; Fujimura S. [Strategy of treatment for roentgenographically occult lung cancer].    Nippon Rinsho 58 (5):
1112-1116, 2000

Enejder AM; af KC; Wang I; Andersson-Engels S; Bendsoe N; Svanberg S; Svanberg K. Blood perfusion studies on basal cell
carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-Doppler perfusion imaging. Acta Derm
Venereol 80 (1): 19-23, 2000

Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fekete F. [Local curative treatment of superficial adenocarcinoma in Barrett's
esophagus. First results of photodynamic therapy with a new photosensitizer]. Bull Acad Natl Med 184 (8): 1731-1744, 2000

Faustino MA; Neves MG; Cavaleiro JA; Neumann M; Brauer HD; Jori G. meso-tetraphenylporphyrin dimer derivatives as potential
photosensitizers in photodynamic therapy. Part 2. Photochem Photobiol 72 (2): 217-225, 2000

Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ. Antiangiogenic treatment enhances photodynamic therapy
responsiveness in a mouse mammary carcinoma. Cancer Res 60 (15): 4066-4069, 2000

Filbeck T; Wimmershoff MB; Pichlmeier U; Karrer S; Wieland WF; Szeimies RM; Rossler W. No generalized skin phototoxicity after
intravesical application of 5-aminolevulinic acid for fluorescence diagnosis of superficial bladder cancer. Urol Int 64 (3): 126-128,
2000

Fingar VH; Taber SW; Haydon PS; Harrison LT; Kempf SJ; Wieman TJ. Vascular damage after photodynamic therapy of solid tumors: a
view and comparison of effect in pre-clinical and clinical models at the University of Louisville. In Vivo 14 (1): 93-100, 2000

Flinn ED. From growing plants to killing tumors. Aerosp Am 38 (4): 24-25, 2000


5
Fong DS. Age-related macular degeneration: update for primary care.     Am Fam Physician 61 (10): 3035-3042, 2000

Fraikin GY; Strakhovskaya MG; Rubin AB. Light-induced processes of cell protection against photodamage. Biochemistry (Mosc ) 65
(6): 737-746, 2000

Frimberger D; Zaak D; Hofstetter A. Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma of the bladder.
Semin Urol Oncol 18 (4): 264-272, 2000

Fritsch C; Neumann NJ; Ruzicka T; Lehmann P. [Photodiagnostic tests. 3: Fluorescence diagnosis with delta-aminolevulinic acid-
induced porphyrins (FDAP) in dermatology]. Hautarzt 51 (7): 528-543, 2000

Fuchs J; Weber S; Kaufmann R. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic
acid: implications for clinical photodynamic therapy. Free Radic Biol Med 28 (4): 537-548, 2000

Fujimura S; Sakurada A; Sagawa M; Saito Y; Takahashi H; Tanita T; Ono S; Matsumura S; Kondo T; Sato M. A therapeutic approach to
roentgenographically occult squamous cell carcinoma of the lung. Cancer 89 (11 Suppl): 2445-2448, 2000

Gahlen J; Stern J; Pressmar J; Bohm J; Holle R; Herfarth C. Local 5-aminolevulinic acid application for laser light-induced fluorescence
diagnosis of early staged colon cancer in rats. Lasers Surg Med 26 (3): 302-307, 2000

Gao H; Luo GA; Feng J; Ottova AL; Tien HT. Fabrication and photoelectric properties of self-assembled bilayer lipid membranes on
conducting glass. J Photochem Photobiol B 59 (1-3): 87-91, 2000

Garcia LA. [Photodynamic therapy]. Arch Soc Esp Oftalmol 75 (10): 655-656, 2000

Gathwala G; Sharma S. Oxidative stress, phototherapy and the neonate. Indian J Pediatr 67 (11): 805-808, 2000

Gerscher S; Connelly JP; Griffiths J; Brown SB; Macrobert AJ; Wong G; Rhodes LE. Comparison of the pharmacokinetics and
phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem
Photobiol 72 (4): 569-574, 2000

Gharehbaghi K; Kubin A; Grusch M; Gharehbaghi-Schnell E; Wierrani F; Jayaram HN; Grunberger W; Szekeres T. Photodynamic
action of meta-tetrahydroxyphenylchlorin (mTHPC) on an ovarian cancer cell line. Anticancer Res 20 (4): 2647-2652, 2000

Gijsens A; de Witte P. [Targeting of chlorine E6 by EGF increasing its photodynamic activity in selective ways].   Verh K Acad
Geneeskd Belg 62 (4): 329-352, 2000

Gijsens A; Missiaen L; Merlevede W; de Witte P. Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its
photodynamic activity. Cancer Res 60 (8): 2197-2202, 2000

Girotti AW; Korytowski W. Cholesterol as a singlet oxygen detector in biological systems.    Methods Enzymol 319: 85-100, 2000

Gjersvik PJ. [Photodynamic therapy--promising or overpraised?].    Tidsskr Nor Laegeforen 120 (19): 2243, 2000

Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den BH; Monnier P; Wagnieres G. Pharmacokinetics and
pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
J Photochem Photobiol B 57 (1): 22-32, 2000

Gohto Y; Obana A; Kaneda K; Nakajima S; Takemura T; Miki T. Accumulation of photosensitizer ATX-S10 (Na) in experimental
corneal neovascularization. Jpn J Ophthalmol 44 (4): 348-353, 2000

Gohto Y; Obana A; Kanai M; Nagata S; Miki T; Nakajima S. Photodynamic therapy for corneal neovascularization using topically
administered ATX-S10 (Na). Ophthalmic Surg Lasers 31 (1): 55-60, 2000

Golab J; Wilczynski G; Zagozdzon R; Stoklosa T; Dabrowska A; Rybczynska J; Wasik M; Machaj E; Olda T; Kozar K; Kaminski R;
Giermasz A; Czajka A; Lasek W; Feleszko W; Jakobisiak M. Potentiation of the anti-tumour effects of Photofrin-based photodynamic
therapy by localized treatment with G-CSF. Br J Cancer 82 (8): 1485-1491, 2000

Gonzalez S; Vibhagool C; Sherwood M; Flotte TJ; Kollias N. The phototoxicity of photodynamic therapy may be suppressed or
enhanced by modulation of the cutaneous vasculature. J Photochem Photobiol B 57 (2-3): 142-148, 2000

Gossner L; Ell C. Photodynamic therapy of gastric cancer.   Gastrointest Endosc Clin N Am 10 (3): 461-480, 2000



6
Goyan RL; Cramb DT. Near-infrared two-photon excitation of protoporphyrin IX: photodynamics and photoproduct generation.
Photochem Photobiol 72 (6): 821-827, 2000

Granville DJ; Carthy CM; Jiang H; Levy JG; McManus BM; Matroule JY; Piette J; Hunt DW. Nuclear factor-kappaB activation by the
photochemotherapeutic agent verteporfin. Blood 95 (1): 256-262, 2000

Grebenova D; Halada P; Stulik J; Havlicek V; Hrkal Z. Protein changes in HL60 leukemia cells associated with 5-aminolevulinic acid-
based photodynamic therapy. Early effects on endoplasmic reticulum chaperones. Photochem Photobiol 72 (1): 16-22, 2000

Greenwald BD. Photodynamic therapy for esophageal cancer. Update. Chest Surg Clin N Am 10 (3): 625-637, 2000

Gronlund-Pakkanen S; Pakkanen TM; Talja M; Kosma VM; Ala-Opas M; Alhava E. The morphological changes in rat bladder after
photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX. BJU Int 86 (1): 126-132, 2000

Guillen C; Sanmartin O; Escudero A; Botella-Estrada R; Sevila A; Castejon P. Photodynamic therapy for in situ squamous cell
carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolaevulinic acid. J Eur Acad Dermatol Venereol 14 (4):
298-300, 2000

Gupta I; Tripathy BC. Oxidative stress in cucumber (Cucumis sativus L) seedlings treated with acifluorfen. Indian J Biochem Biophys
37 (6): 498-505, 2000

Haddad R; Kaplan O; Greenberg R; Siegal A; Skornick Y; Kashtan H. Photodynamic therapy of murine colon cancer and melanoma
using systemic aminolevulinic acid as a photosensitizer. Int J Surg Investig 2 (3): 171-178, 2000

Haller JC; Cairnduff F; Slack G; Schofield J; Whitehurst C; Tunstall R; Brown SB; Roberts DJ. Routine double treatments of superficial
basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 143 (6): 1270-1275, 2000

Hamblin MR; Del Governatore M; Rizvi I; Hasan T. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of
hepatic metastasis of colorectal cancer. Br J Cancer 83 (11): 1544-1551, 2000

Hamblin MR; Miller JL; Ortel B. Scavenger-receptor targeted photodynamic therapy.      Photochem Photobiol 72 (4): 533-540, 2000

Harat M; Sokal P. [Use of stereotactic methods in neurosurgery practice].   Neurol Neurochir Pol 34 (5): 973-982, 2000

Harrer G. [Hypericum and phototherapy]. Schweiz Rundsch Med Prax 89 (50): 2123-2129, 2000

He YY; Jiang LJ. Synthesis and EPR investigations of new aminated hypocrellin derivatives.    Free Radic Biol Med 28 (11): 1642-
1651, 2000

Heckenkamp J; Adili F; Kishimoto J; Koch M; LaMuraglia GM. Local photodynamic action of methylene blue favorably modulates the
postinterventional vascular wound healing response. J Vasc Surg 31 (6): 1168-1177, 2000

Henderson BW; Busch TM; Vaughan LA; Frawley NP; Babich D; Sosa TA; Zollo JD; Dee AS; Cooper MT; Bellnier DA; Greco WR;
Oseroff AR. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during
treatment, depending on fluence rate. Cancer Res 60 (3): 525-529, 2000

Hendrich C; Huttmann G; Vispo-Seara JL; Houserek S; Siebert WE. Experimental photodynamic laser therapy for rheumatoid arthritis
with a second generation photosensitizer. Knee Surg Sports Traumatol Arthrosc 8 (3): 190-194, 2000

Hettiaratchy S; Clarke J; Taubel J; Besa C. Burns after photodynamic therapy. BMJ 320 (7244): 1245, 2000

Hillemanns P; Weingandt H; Stepp H; Baumgartner R; Xiang W; Korell M. Assessment of 5-aminolevulinic acid-induced porphyrin
fluorescence in patients with peritoneal endometriosis. Am J Obstet Gynecol 183 (1): 52-57, 2000

Hillemanns P; Untch M; Dannecker C; Baumgartner R; Stepp H; Diebold J; Weingandt H; Prove F; Korell M. Photodynamic therapy of
vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer 85 (5): 649-653, 2000

Hinnen P; de Rooij FW; Voortman G; Tilanus HW; Wilson JH; Siersema PD. Acrylate yellow filters in operating lights protect against
photosensitization tissue damage. Br J Surg 87 (2): 231-235, 2000

Hinnen P; de Rooij FW; Terlouw EM; Edixhoven A; van Dekken H; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD.
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid. Br J Cancer 83
(4): 539-543, 2000


7
Honey CR; Obochi MO; Shen H; Margaron P; Yip S; Levy JG. Reduced xenograft rejection in rat striatum after pretransplant
photodynamic therapy of murine neural xenografts. J Neurosurg 92 (1): 127-131, 2000

Hongcharu W; Taylor CR; Chang Y; Aghassi D; Suthamjariya K; Anderson RR. Topical ALA-photodynamic therapy for the treatment
of acne vulgaris. J Invest Dermatol 115 (2): 183-192, 2000

Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1: 212-219, 2000

Horio Y; Watanabe F; Shirakawa K; Kageoka M; Iwasaki H; Maruyama Y; Honda S; Kitayama Y; Hanai H. Schwannoma of the
sigmoid colon. Gastrointest Endosc 52 (4): 528, 2000

Hornung R; Fehr MK; Walt H; Wyss P; Berns MW; Tadir Y. PEG-m-THPC-mediated photodynamic effects on normal rat tissues.
Photochem Photobiol 72 (5): 696-700, 2000

Hrkal Z; Cajthamlova H; Grebenova D; Bartosova J; Klamova H; Marinov J. [Selective photodynamic destruction of leukemic cells].
Cas Lek Cesk 139 (5): 148-154, 2000

Huang J; Liu E; Dai Z; Shen C; Yang S; Chen N; Huang J. [The molecular spectra and existence state of sulfonated phthalimidomethyl
phthalocyanine hydroxyl aluminum as amphiphilic photosensitizer in aqueous alcoholic solutions and water]. Guang Pu Xue Yu Guang
Pu Fen Xi 20 (5): 673-676, 2000

Huang J; Liu E; Yang S; Chen N; Huang J; Duan J; Chen Y. [The monomer electronic spectra and fluorescence spectra of some metal
phthalocyanines]. Guang Pu Xue Yu Guang Pu Fen Xi 20 (1): 95-98, 2000

Hunt DW; Chan AH. Influence of photodynamic therapy on immunological aspects of disease - an update. Expert Opin Investig Drugs
9 (4): 807-817, 2000

Itoh Y; Ninomiya Y; Henta T; Tajima S; Ishibashi A. Intraoperative detection of 5-aminolaevulinic acid-induced protoporphyrin
fluorescence in lymph node metastases after oral administration. Br J Dermatol 142 (3): 567-569, 2000

Itoh Y; Ninomiya Y; Tajima S; Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol
136 (9): 1093-1095, 2000

Itoh Y; Henta T; Ninomiya Y; Tajima S; Ishibashi A. Repeated 5-aminolevulinic acid-based photodynamic therapy following electro-
curettage for pigmented basal cell carcinoma. J Dermatol 27 (1): 10-15, 2000

Itoh Y; Ninomiya Y; Henta T; Tajima S; Ishibashi A. Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic
keratoses. J Dermatol 27 (8): 513-518, 2000

Jacobs TM; Rosen GM. Photodynamic therapy as a treatment for esophageal squamous cell carcinoma in a dog.      J Am Anim Hosp
Assoc 36 (3): 257-261, 2000

Jeffes EW, III; Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol 1 (3): 167-179, 2000

Jenkins MP; Buonaccorsi GA; Mansfield R; Bishop CC; Bown SG; McEwan JR. Reduction in the response to coronary and iliac artery
injury with photodynamic therapy using 5-aminolaevulinic acid. Cardiovasc Res 45 (2): 478-485, 2000

Jin ZH; Miyoshi N; Ishiguro K; Umemura S; Kawabata K; Yumita N; Sakata I; Takaoka K; Udagawa T; Nakajima S; Tajiri H; Ueda K;
Fukuda M; Kumakiri M. Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinom a
in C3H/HeN mice. J Dermatol 27 (5): 294-306, 2000

Jin ZH; Miyoshi N; Ishiguro K; Takaoka K; Udagawa T; Tajiri H; Ueda K; Fukuda M; Kumakiri M. Photodynamic therapy based on
combined use of 5-aminolevulinic acid with a pheophorbide-a derivative for murine tumors. In Vivo 14 (4): 529-533, 2000

Jones LM; Mair EA; Fitzpatrick TM; Lyon RD; Feuerstein IM. Multidisciplinary airway stent team: a comprehensive approach and
protocol for tracheobronchial stent treatment. Ann Otol Rhinol Laryngol 109 (10 Pt 1): 889-898, 2000

Kalka K; Merk H; Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 42 (3): 389-413, 2000

Kalka K; Ahmad N; Criswell T; Boothman D; Mukhtar H. Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-
mediated apoptosis of tumor cells and ablation of mouse skin tumors. Cancer Res 60 (21): 5984-5987, 2000




8
Kamano H; Okamoto K; Sakata I; Kubota Y; Tanaka T. Photodynamic effects of gallium-metal porphyrin on human leukemia cells in
combination with high-brightness LED light: application for autologous bone marrow transplantation. Transplant Proc 32 (7): 2442-
2443, 2000

Kamat JP; Devasagayam TP. Oxidative damage to mitochondria in normal and cancer tissues, and its modulation.       Toxicology 155 (1-
3): 73-82, 2000

Kamuhabwa AR; Agostinis P; D'Hallewin MA; Kasran A; de Witte PA. Photodynamic activity of hypericin in human urinary bladder
carcinoma cells. Anticancer Res 20 (4): 2579-2584, 2000

Kanai M; Obana A; Gohto Y; Nagata S; Miki T; Kaneda K; Nakajima S. Long-term effectiveness of photodynamic therapy by using a
hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats. Lasers Surg Med 26 (1): 48-57,
2000

Kanofsky JR; Sima PD. Preferential cytotoxicity for multidrug-resistant K562 cells using the combination of a photosensitizer and a
cyanine dye. J Photochem Photobiol B 54 (2-3): 136-144, 2000

Kaplan MA; Romanko I. [Photodynamic therapy as a new radical therapeutic method in patients with relapsing tumors at "inaccessible"
sites]. Vopr Onkol 46 (2): 238, 2000

Karrer S; Abels C; Landthaler M; Szeimies RM. Topical photodynamic therapy for localized scleroderma.      Acta Derm Venereol 80
(1): 26-27, 2000

Kashiwagi H; Spigelman AD. Gastroduodenal lesions in familial adenomatous polyposis.       Surg Today 30 (8): 675-682, 2000

Kassab K; Fabris C; Defilippis MP; Dei D; Fantetti L; Roncucci G; Reddi E; Jori G. Skin-photosensitizing properties of Zn(II)-2(3),
9(10), 16(17), 23(24)-tetrakis-(4-oxy-N-methylpiperidinyl) phthalocyanine topically administered to mice. J Photochem Photobiol B
55 (2-3): 128-137, 2000

Kawaguchi T; Yamamoto S; Naka N; Okishio K; Atagi S; Ogawara M; Hosoe S; Kawahara M; Furuse K. Immunohistochemical analysis
of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy. Br J Cancer 82 (2): 418-423,
2000

Kazama T; Takeuchi K; Ikeda K; Ikeda T; Kikura M; Iida T; Suzuki S; Hanai H; Sato S. Optimal propofol plasma concentration during
upper gastrointestinal endoscopy in young, middle-aged, and elderly patients. Anesthesiology 93 (3): 662-669, 2000

Kazi AA; Peyman GA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi D; Moshfeghi AA. Threshold power levels for NPe6
photodynamic therapy. Ophthalmic Surg Lasers 31 (2): 136-142, 2000

Kessel D; Luo Y. Cells in cryptophycin-induced cell-cycle arrest are susceptible to apoptosis. Cancer Lett 151 (1): 25-29, 2000

Kessel D; Caruso JA; Reiners JJ, Jr. Potentiation of photodynamic therapy by ursodeoxycholic acid.   Cancer Res 60 (24): 6985-6988,
2000

Kessel D; Poretz RD. Sites of photodamage induced by photodynamic therapy with a chlorin e6 triacetoxymethyl ester (CAME).
Photochem Photobiol 71 (1): 94-96, 2000

Khadem JJ; Dana MR. Photodynamic biologic tissue glue in perforating rabbit corneal wounds. J Clin Laser Med Surg 18 (3): 125-
129, 2000

Klaase JM; Swaanenburg JC; Schouwink H; Sosef MN; Bonfrer JM; Zoetmulder FA; Rutgers EJ; Baas P. Monitoring of impending
myocardial damage after pleuropneumonectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma using
biochemical markers. Photochem Photobiol 71 (3): 351-354, 2000

Kochli OR. Endometrial ablation in the year 2000--do we have more methods than indications? Contrib Gynecol Obstet 20: 91-120,
2000

Komath SS; Bhanu K; Maiya BG; Swamy MJ. Binding of porphyrins by the tumor-specific lectin, jacalin [Jack fruit (Artocarpus
integrifolia) agglutinin]. Biosci Rep 20 (4): 265-276, 2000

Komath SS; Kenoth R; Giribabu L; Maiya BG; Swamy MJ. Fluorescence and absorption spectroscopic studies on the interaction of
porphyrins with snake gourd (Trichosanthes anguina) seed lectin. J Photochem Photobiol B 55 (1): 49-55, 2000


9
Komerik N; Wilson M; Poole S. The effect of photodynamic action on two virulence factors of gram-negative bacteria.     Photochem
Photobiol 72 (5): 676-680, 2000

Konaka C; Usuda J; Kato H. [Preoperative photodynamic therapy for lung cancer].     Nippon Geka Gakkai Zasshi 101 (7): 486-489,
2000

Konig K. Multiphoton microscopy in life sciences.   J Microsc 200 ( Pt 2): 83-104, 2000

Konig K; Teschke M; Sigusch B; Glockmann E; Eick S; Pfister W. Red light kills bacteria via photodynamic action.     Cell Mol Biol
(Noisy -le-grand) 46 (7): 1297-1303, 2000

Korbelik M; Parkins CS; Shibuya H; Cecic I; Stratford MR; Chaplin DJ. Nitric oxide production by tumour tissue: impact on the
response to photodynamic therapy. Br J Cancer 82 (11): 1835-1843, 2000

Koros E; Varga M. [A glimpse into a new discipline: medicinal inorganic chemistry].    Acta Pharm Hung 70 (3-6): 196-202, 2000

Krieg RC; Fickweiler S; Wolfbeis OS; Knuechel R. Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro.
Photochem Photobiol 72 (2): 226-233, 2000

Krishna CM; Bose B; Gupta PK. N2 laser-induced oxidation of hemoproteins in red blood cell lysate. Radiat Res 153 (4): 411-415,
2000

Krishnadath KK; Wang KK; Taniguchi K; Sebo TJ; Buttar NS; Anderson MA; Lutzke LS; Liu W. Persistent genetic abnormalities in
Barrett's esophagus after photodynamic therapy. Gastroenterology 119 (3): 624-630, 2000

Krishnamurthy S; Powers SK; Witmer P; Brown T. Optimal light dose for interstitial photodynamic therapy in treatment for malignant
brain tumors. Lasers Surg Med 27 (3): 224-234, 2000

Kubba AK; Krasner N. An update in the palliative management of malignant dysphagia.       Eur J Surg Oncol 26 (2): 116-129, 2000

Kulapaditharom B; Boonkitticharoen V. Photodynamic therapy in management of head and neck cancers and precancerous lesions. J
Med Assoc Thai 83 (3): 249-258, 2000

Kurwa HA; Barlow RJ; Neill S. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to
conventional therapy. Br J Dermatol 143 (5): 1040-1042, 2000

Kusuzaki K; Minami G; Takeshita H; Murata H; Hashiguchi S; Nozaki T; Ashihara T; Hirasawa Y. Photodynamic inactivation with
acridine orange on a multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res 91 (4): 439-445, 2000

Kusuzaki K; Aomori K; Suginoshita T; Minami G; Takeshita H; Murata H; Hashiguchi S; Ashihara T; Hirasawa Y. Total tumor cell
elimination with minimum damage to normal tissues in musculoskeletal sarcomas following photodynamic therapy with acridine orange.
Oncology 59 (2): 174-180, 2000

Lagerberg JW; Uberriegler KP; Krammer B; vanSteveninck J; Dubbelman TM. Plasma membrane properties involved in the
photodynamic efficacy of merocyanine 540 and tetrasulfonated aluminum phthalocyanine. Photochem Photobiol 71 (3): 341-346,
2000

Lagoda TS; Kaplan MA; Krivosheev I; Zhavoronkov LP; Bokova MB. [The optimization of a plan for the photodynamic therapy of
sarcoma M1 using photosens]. Vopr Onkol 46 (3): 327-331, 2000

Lambert R. Endoscopic mucosectomy: an alternative treatment for superficial esophageal cancer.    Recent Results Cancer Res 155:
183-192, 2000

LaMuraglia GM; Schiereck J; Heckenkamp J; Nigri G; Waterman P; Leszczynski D; Kossodo S. Photodynamic therapy induces
apoptosis in intimal hyperplastic arteries. Am J Pathol 157 (3): 867-875, 2000

Lavie G; Meruelo D; Aroyo K; Mandel M. Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for
treatment of T cell-mediated diseases. Int Immunol 12 (4): 479-486, 2000

Ledo E; Ledo A. Phototherapy, photochemotherapy, and photodynamic therapy: unapproved uses or indications.       Clin Dermatol 18
(1): 77-86, 2000

Leman JA; Benton EC. Verrucas. Guidelines for management.       Am J Clin Dermatol 1 (3): 143-149, 2000


10
Leonard KA; Hall JP; Nelen MI; Davies SR; Gollnick SO; Camacho S; Oseroff AR; Gibson SL; Hilf R; Detty MR. A selenopyrylium
photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term
skin photosensitization. J Med Chem 43 (23): 4488-4498, 2000

Lermontova I; Grimm B. Overexpression of plastidic protoporphyrinogen IX oxidase leads to resistance to the diphenyl-ether herbicide
acifluorfen. Plant Physiol 122 (1): 75-84, 2000

Leunig A; Betz CS; Baumgartner R; Grevers G; Issing WJ. Initial experience in the treatment of oral leukoplakia with high-dose vitamin
A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence. Eur Arch Otorhinolaryngol 257 (6): 327-331, 2000

Li L; Chen Y; Shen J; Zhang M; Shen T. New long-wavelength perylenequinones: synthesis and phototoxicity of hypocrellin B
derivatives. Biochim Biophys Acta 1523 (1): 6-12, 2000

Liang H; Do T; Kasravi S; Aurasteh P; Nguyen A; Huang A; Wang Z; Berns MW. Chromosomes are target sites for photodynamic
therapy as demonstrated by subcellular laser microirradiation. J Photochem Photobiol B 54 (2-3): 175-184, 2000

Lightdale CJ. Role of photodynamic therapy in the management of advanced esophageal cancer.       Gastrointest Endosc Clin N Am 10
(3): 397-408, 2000

Lilge L; Portnoy M; Wilson BC. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br
J Cancer 83 (8): 1110-1117, 2000

Liu CD; Kwan D; Saxton RE; McFadden DW. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in
vivo. J Surg Res 93 (1): 137-143, 2000

Lopatkin NA; Kamalov AA; Kudriavtsev I; Tokarev FV. [Fluorescent diagnostics of urinary bladder cancer].       Urologiia (4): 3-6,
2000

Lord GA; Cai H; Luo JL; Lim CK. HPLC-electrospray mass spectrometry for the analysis of temoporfin-poly(ethylene glycol)
conjugates. Analyst 125 (4): 605-608, 2000

Lucroy MD; Edwards BF; Madewell BR. Veterinary photodynamic therapy. J Am Vet Med Assoc 216 (11): 1745-1751, 2000

Luketich JD; Christie NA; Buenaventura PO; Weigel TL; Keenan RJ; Nguyen NT. Endoscopic photodynamic therapy for obstructing
esophageal cancer: 77 cases over a 2-year period. Surg Endosc 14 (7): 653-657, 2000

Luna MC; Ferrario A; Wong S; Fisher AM; Gomer CJ. Photodynamic therapy-mediated oxidative stress as a molecular switch for the
temporal expression of genes ligated to the human heat shock promoter. Cancer Res 60 (6): 1637-1644, 2000

Madsen SJ; Sun CH; Tromberg BJ; Wallace VP; Hirschberg H. Photodynamic therapy of human glioma spheroids using 5-
aminolevulinic acid. Photochem Photobiol 72 (1): 128-134, 2000

Mahy P; Thone M; Reychler H. [Principles and therapeutic elements of lesions of the oral mucosa].     Rev Belge Med Dent 55 (3): 251-
276, 2000

Maier A; Tomaselli F; Anegg U; Rehak P; Fell B; Luznik S; Pinter H; Smolle-Juttner FM. Combined photodynamic therapy and
hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction. Eur J Cardiothorac Surg 18 (6): 649-654,
2000

Maier A; Anegg U; Tomaselli F; Rehak P; Sankin O; Fell B; Renner H; Pinter H; Smolle-Juttner FM; Friehs GB. Does hyperbaric
oxygen enhance the effect of photodynamic therapy in patients with advanced esophageal carcinoma? A clinical pilot study. Endoscopy
32 (1): 42-48, 2000

Maier A; Anegg U; Fell B; Tomaselli F; Sankin O; Prettenhofer U; Pinter H; Rehak P; Friehs GB; Smolle-Juttner FM. Effect of
photodynamic therapy in a multimodal approach for advanced carcinoma of the gastro-esophageal junction. Lasers Surg Med 26 (5):
461-466, 2000

Maier A; Anegg U; Fell B; Rehak P; Ratzenhofer B; Tomaselli F; Sankin O; Pinter H; Smolle-Juttner FM; Friehs GB. Hyperbaric
oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus. Lasers Surg Med 26 (3):
308-315, 2000




11
Maier A; Woltsche M; Fell B; Prettenhofer U; Domej W; Roger GM; Pinter H; Smolle-Juttner FM. Local and systemic treatment in
small cell carcinoma of the esophagus. Oncol Rep 7 (1): 187-192, 2000

Maier A; Tomaselli F; Gebhard F; Rehak P; Smolle J; Smolle-Juttner FM. Palliation of advanced esophageal carcinoma by
photodynamic therapy and irradiation. Ann Thorac Surg 69 (4): 1006-1009, 2000

Malhi-Chowla N; Ringley RK; Wolfsen HC. Gastric metaplasia of the proximal esophagus associated with esophageal adenocarcinoma
and Barrett's esophagus: what is the connection? Inlet patch revisited. Dig Dis 18 (3): 183-185, 2000

Malik E; Berg C; Meyhofer-Malik A; Buchweitz O; Moubayed P; Diedrich K. Fluorescence diagnosis of endometriosis using 5-
aminolevulinic acid. Surg Endosc 14 (5): 452-455, 2000

Malik E; Meyhofer-Malik A; Berg C; Bohm W; Kunzi-Rapp K; Diedrich K; Ruck A. Fluorescence diagnosis of endometriosis on the
chorioallantoic membrane using 5-aminolaevulinic acid. Hum Reprod 15 (3): 584-588, 2000

Margherio RR; Margherio AR; DeSantis ME. Laser treatments with verteporfin therapy and its potential impact on retinal practices.
Retina 20 (4): 325-330, 2000

Marks PV; Belchetz PE; Saxena A; Igbaseimokumo U; Thomson S; Nelson M; Stringer MR; Holroyd JA; Brown SB. Effect of
photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial--an early report. Br J Neurosurg 14 (4): 317-325, 2000

Martens A; de Moor A; Waelkens E; Merlevede W; de Witte P. In vitro and in vivo evaluation of hypericin for photodynamic therapy of
equine sarcoids. Vet J 159 (1): 77-84, 2000

Marti C; Nonell S; Nicolau M; Torres T. Photophysical properties of neutral and cationic tetrapyridinoporphyrazines.   Photochem
Photobiol 71 (1): 53-59, 2000

Matile P. Biochemistry of Indian summer: physiology of autumnal leaf coloration.    Exp Gerontol 35 (2): 145-158, 2000

Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov I. [Role of fluorescent control in raising radicality of surgical
treatment for superficial bladder cancer]. Urologiia (3): 22-24, 2000

McCaw DL; Pope ER; Payne JT; West MK; Tompson RV; Tate D. Treatment of canine oral squamous cell carcinomas with
photodynamic therapy. Br J Cancer 82 (7): 1297-1299, 2000

Melnikova VO; Bezdetnaya LN; Brault D; Potapenko AY; Guillemin F. Enhancement of meta-tetrahydroxyphenylchlorin-sensitized
photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox. Int J Cancer 88 (5): 798-803,
2000

Mesenholler M; Matthews EK. A key role for the mitochondrial benzodiazepine receptor in cellular photosensitisation with delta-
aminolaevulinic acid. Eur J Pharmacol 406 (2): 171-180, 2000

Messmann H. [Fluorescence endoscopy in gastroenterology]. Z Gastroenterol 38 (1): 21-30, 2000

Michels S; Barbazetto I; Schmidt-Erfurth U. [Choroidal changes after photodynamic therapy (PDT). A two-year follow-up study of 38
patients]. Klin Monatsbl Augenheilkd 217 (2): 94-99, 2000

Mitra S; Foster TH. Photochemical oxygen consumption sensitized by a porphyrin phosphorescent probe in two model systems.
Biophys J 78 (5): 2597-2605, 2000

Moghissi K; Dixon K; Thorpe JA; Stringer M; Moore PJ. The role of photodynamic therapy (PDT) in inoperable oesophageal cancer.
Eur J Cardiothorac Surg 17 (2): 95-100, 2000

Monga SP; Wadleigh R; Sharma A; Adib H; Strader D; Singh G; Harmon JW; Berlin M; Monga DK; Mishra L. Intratumoral therapy of
cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer. Am J Clin Oncol 23 (4): 386-392,
2000

Moor AC. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B 57 (1): 1-13, 2000

Morgan J; Potter WR; Oseroff AR. Comparison of photodynamic targets in a carcinoma cell line and its mitochondrial DNA -deficient
derivative. Photochem Photobiol 71 (6): 747-757, 2000




12
Mori M; Kuroda T; Obana A; Sakata I; Hirano T; Nakajima S; Hikida M; Kumagai T. In vitro plasma protein binding and cellular uptake
of ATX-S10(Na), a hydrophilic chlorin photosensitizer. Jpn J Cancer Res 91 (8): 845-852, 2000

Mori M; Sakata I; Hirano T; Obana A; Nakajima S; Hikida M; Kumagai T. Photodynamic therapy for experimental tumors using ATX-
S10(Na), a hydrophilic chlorin photosensitizer, and diode laser. Jpn J Cancer Res 91 (7): 753-759, 2000

Morris K. Ray of light for treatment of head and neck cancer.   Lancet Oncol 1 (1): 10, 2000

Morton CA; Whitehurst C; Moore JV; MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by
photodynamic therapy. Br J Dermatol 143 (4): 767-772, 2000

Morton CA. Photodynamic therapy. Hosp Med 61 (4): 289, 2000

Nagy B; Chiu SM; Separovic D. Fumonisin B1 does not prevent apoptosis in A431 human epidermoid carcinoma cells after
photosensitization with a silicon phthalocyanine. J Photochem Photobiol B 57 (2-3): 132-141, 2000

Nakamura J; Sumiyama Y; Kajiwara H; Nakamura M; Watanabe M; Tanaka H; Terada T; Nagao J; Kusachi S; Saida Y; Usui S; Aizawa
K. [Photodynamic diagnosis and photodynamic therapy for experimental hepatoma with ME 2906]. Gan To Kagaku Ryoho 27 (12):
1876-1878, 2000

Nakamura T; Fukui H; Ishii Y; Fujita M; Hori K; Ejiri K; Ejiri M; Fujimori T. Shape-memory alloy loop snare for endoscopic
photodynamic therapy of early gastric cancer. Endoscopy 32 (8): 609-613, 2000

Obana A; Gohto Y; Kanai M; Nakajima S; Kaneda K; Miki T. Selective photodynamic effects of the new photosensitizer ATX-S10(Na)
on choroidal neovascularization in monkeys. Arch Ophthalmol 118 (5): 650-658, 2000

Oda K; Ogura S; Okura I. Preparation of a water-soluble fluorinated zinc phthalocyanine and its effect for photodynamic therapy.       J
Photochem Photobiol B 59 (1-3): 20-25, 2000

Okamoto K; Kamano H; Sakata I. Development of a novel LED apparatus for photodynamic purging of leukemia cells in hematopoietic
stem-cell transplantation. Transplant Proc 32 (7): 2444-2446, 2000

Oldham TC; Phillips D. Triplet-state photophysics of aluminium phthalocyanine sensitizer in murine cancer cells.     J Photochem
Photobiol B 55 (1): 16-19, 2000

Olejek A; Sieron A; Urban A; Drebkowski A; Biniszkiewicz T. [Use of photodynamic methods in diagnosis and therapy of epithelial
vulvar diseases]. Wiad Lek 53 (9-10): 546-551, 2000

Orenstein A; Haik J; Tamir J; Winkler E; Trau H; Malik Z; Kostenich G. Photodynamic therapy of cutaneous lymphoma using 5-
aminolevulinic acid topical application. Dermatol Surg 26 (8): 765-769, 2000

Ormrod D; Jarvis B. Topical aminolevulinic acid HCl photodynamic therapy.       Am J Clin Dermatol 1 (2): 133-139, 2000

Orth K; Russ D; Steiner R; Beger HG. Fluorescence detection of small gastrointestinal tumours: principles, technique, first clinical
experience. Langenbecks Arch Surg 385 (7): 488-494, 2000

Orth K; Beck G; Genze F; Ruck A. Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice.           J
Photochem Photobiol B 57 (2-3): 186-192, 2000

Ortner MA. Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest Endosc Clin N Am 10 (3): 481-486, 2000

Osada K; Sevanian A. Cholesterol photodynamic oxidation by ultraviolet irradiation and cholesterol ozonization by ozone exposure.
Methods Enzymol 319: 188-196, 2000

Ost D. Photodynamic therapy in lung cancer.     Oncology (Williston Park) 14 (3): 379-86, 391, 2000

Overhaus M; Heckenkamp J; Kossodo S; Leszczynski D; LaMuraglia GM. Photodynamic therapy generates a matrix barrier to invasive
vascular cell migration. Circ Res 86 (3): 334-340, 2000

Overholt BF. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia. Am J Manag Care 6 (16 Suppl): S903-
S908, 2000




13
Overholt BF; Panjehpour M. Photodynamic therapy in the management of Barrett's esophagus with dysplasia.      J Gastrointest Surg 4
(2): 129-130, 2000

Panjehpour M; Overholt BF; Haydek JM. Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract.
Gastrointest Endosc Clin N Am 10 (3): 513-532, 2000

Panjehpour M; Overholt BF; Haydek JM; Lee SG. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's
esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 95 (9): 2177-2184, 2000

Pari K; Sundari CS; Chandani S; Balasubramanian D. beta-carbolines that accumulate in human tissues may serve a protective role
against oxidative stress. J Biol Chem 275 (4): 2455-2462, 2000

Peng Y; Xue J; Huang J; Lin Z; Liu E; Chen N; Huang J. [Study on the aggregation state of sulfonated phthalimidomethyl zinc
phthalocyanine in CEL solution]. Guang Pu Xue Yu Guang Pu Fen Xi 20 (6): 875-877, 2000

Peyman GA; Kazi AA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi DM. Problems with and pitfalls of photodynamic therapy.
Ophthalmology 107 (1): 29-35, 2000

Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I. Threshold and retreatment parameters of NPe6
photodynamic therapy in retinal and choroidal vessels. Ophthalmic Surg Lasers 31 (4): 323-327, 2000

Pons P; Pittau RF; Boetto NA; Garzon R; Aoki A. [Prototype of light source for photodynamic therapy in Centre of Electron
Microscopy]. Rev Fac Cien Med Univ Nac Cordoba 57 (1): 31-36, 2000

Potocky M; Trnavec B. [Etiopathogenesis of age-related macular degeneration and present possibilities of treatment]. Bratisl Lek Listy
101 (4): 231-233, 2000

Radu A; Wagnieres G; van den BH; Monnier P. Photodynamic therapy of early squamous cell cancers of the esophagus.       Gastrointest
Endosc Clin N Am 10 (3): 439-460, 2000

Rafanan AL; Mehta AC. Role of bronchoscopy in lung cancer.      Semin Respir Crit Care Med 21 (5): 405-420, 2000

Regillo CD. Update on photodynamic therapy. Curr Opin Ophthalmol 11 (3): 166-170, 2000

Reinbothe S; Mache R; Reinbothe C. A second, substrate-dependent site of protein import into chloroplasts.   Proc Natl Acad Sci U S A
97 (17): 9795-9800, 2000

Renno RZ; Delori FC; Holzer RA; Gragoudas ES; Miller JW. Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its
effect is potentiated by angiostatin in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 41 (12): 3963-3971, 2000

Rhodes LE. Photodynamic therapy. Hosp Med 61 (3): 160-161, 2000

Rivellese MJ; Baumal CR. Photodynamic therapy of eye diseases. J Ophthalmic Nurs Technol 19 (3): 134-141, 2000

Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM. Topical 5-aminolevulinic acid-photodynamic therapy of hairless
mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Photochem
Photobiol 72 (6): 794-802, 2000

Rockson SG; Kramer P; Razavi M; Szuba A; Filardo S; Fitzgerald P; Cooke JP; Yousuf S; DeVault AR; Renschler MF; Adelman DC.
Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium
(Antrin). Circulation 102 (19): 2322-2324, 2000

Rockson SG; Lorenz DP; Cheong WF; Woodburn KW. Photoangioplasty: An emerging clinical cardiovascular role for photodynamic
therapy. Circulation 102 (5): 591-596, 2000

Rokitskaya TI; Block M; Antonenko YN; Kotova EA; Pohl P. Photosensitizer binding to lipid bilayers as a precondition for the
photoinactivation of membrane channels. Biophys J 78 (5): 2572-2580, 2000

Rosenkranz AA; Jans DA; Sobolev AS. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency.
Immunol Cell Biol 78 (4): 452-464, 2000




14
Roslaniec M; Weitman H; Freeman D; Mazur Y; Ehrenberg B. Liposome binding constants and singlet oxygen quantum yields of
hypericin, tetrahydroxy helianthrone and their derivatives: studies in organic solutions and in liposomes. J Photochem Photobiol B 57
(2-3): 149-158, 2000

Rousset N; Vonarx V; Eleouet S; Carre J; Bourre L; Lajat Y; Patrice T. Cellular distribution and phototoxicity of benzoporphyrin
derivative and Photofrin. Res Exp Med (Berl) 199 (6): 341-357, 2000

Rousset N; Keminon E; Eleouet S; Le Neel T; Auget JL; Vonarx V; Carre J; Lajat Y; Patrice T. Use of alkaline Comet assay to assess
DNA repair after m-THPC-PDT. J Photochem Photobiol B 56 (2-3): 118-131, 2000

Rovaldi CR; Pievsky A; Sole NA; Friden PM; Rothstein DM; Spacciapoli P. Photoactive porphyrin derivative with broad-spectrum
activity against oral pathogens In vitro. Antimicrob Agents Chemother 44 (12): 3364-3367, 2000

Rovers JP; Saarnak AE; de Jode M; Sterenborg HJ; Terpstra OT; Grahn MF. Biodistribution and bioactivity of tetra-pegylated meta-
tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model. Photochem Photobiol 71
(2): 211-217, 2000

Rovers JP; de Jode ML; Rezzoug H; Grahn MF. In vivo photodynamic characteristics of the near-infrared photosensitizer 5,10,15,20-
tetrakis(M-hydroxyphenyl) bacteriochlorin. Photochem Photobiol 72 (3): 358-364, 2000

Rovers JP; de Jode ML; Grahn MF. Significantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-
hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue. Lasers Surg Med 27 (3): 235-240, 2000

Ruck A; Heckelsmiller K; Kaufmann R; Grossman N; Haseroth E; Akgun N. Light-induced apoptosis involves a defined sequence of
cytoplasmic and nuclear calcium release in AlPcS4-photosensitized rat bladder RR 1022 epithelial cells. Photochem Photobiol 72 (2):
210-216, 2000

Rud E; Gederaas O; Hogset A; Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma
cells by system BETA transporters. Photochem Photobiol 71 (5): 640-647, 2000

Runfola MA; Weber TK; Rodriguez-Bigas MA; Dougherty TJ; Petrelli NJ. Photodynamic therapy for residual neoplasms of the perianal
skin. Dis Colon Rectum 43 (4): 499-502, 2000

Rungta A; Zheng G; Missert JR; Potter WR; Dougherty TJ; Pandey RK. Purpurinimides as photosensitizers: effect of the presence and
position of the substituents in the in vivo photodynamic efficacy. Bioorg Med Chem Lett 10 (13): 1463-1466, 2000

Sahota B; Potter MJ. The nursing process in photodynamic therapy. J Ophthalmic Nurs Technol 19 (5): 252-254, 2000

Saito K; Mikuniya N; Aizawa K. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the
antitumor effect. Jpn J Cancer Res 91 (5): 560-565, 2000

Savoye G; Michel P; Hochain P; Savoye-Collet C; Herve S; Del Gallo GD; Ducrotte P. Fatal acalculous cholecystitis after photodynamic
therapy for high-grade dysplasia of the major duodenal papilla. Gastrointest Endosc 51 (4 Pt 1): 493-495, 2000

Schafer M; Schmitz C; Facius R; Horneck G; Milow B; Funken KH; Ortner J. Systematic study of parameters influencing the action of
Rose Bengal with visible light on bacterial cells: comparison between the biological effect and singlet -oxygen production. Photochem
Photobiol 71 (5): 514-523, 2000

Schempp CM; Ludtke R; Winghofer B; Simon JC. Effect of topical application of Hypericum perforatum extract (St. John's wort) on
skin sensitivity to solar simulated radiation. Photodermatol Photoimmunol Photomed 16 (3): 125-128, 2000

Schempp CM; Winghofer B; Ludtke R; Simon-Haarhaus B; Schopf E; Simon JC. Topical application of St John's wort (Hypericum
perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Dermatol 142 (5): 979-
984, 2000

Schmidt-Erfurth U; Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular
degeneration. Surv Ophthalmol 45 (3): 195-214, 2000

Schunck T; Poulet P. Oxygen consumption through metabolism and photodynamic reactions in cells cultured on microbeads. Phys Med
Biol 45 (1): 103-119, 2000

Scott LJ; Goa KL. Verteporfin.   Drugs Aging 16 (2): 139-146, 2000


15
Sessler JL; Miller RA. Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy. Biochem
Pharmacol 59 (7): 733-739, 2000

Sgarbossa A; Angelini N; Gioffre D; Youssef T; Lenci F; Roberts JE. The uptake, location and fluorescence of hypericin in bovine intact
lens. Curr Eye Res 21 (2): 597-601, 2000

Shackley DC; Whitehurst C; Moore JV; George NJ; Betts CD; Clarke NW. Light penetration in bladder tissue: implications for the
intravesical photodynamic therapy of bladder tumours. BJU Int 86 (6): 638-643, 2000

Shah SK; Ost D. Photodynamic therapy: a case series demonstrating its role in patients receiving mechanical ventilation.   Chest 118
(5): 1419-1423, 2000

Sharman WM; Allen CM; van Lier JE. Role of activated oxygen species in photodynamic therapy.        Methods Enzymol 319: 376-400,
2000

Sheski FD; Mathur PN. Endoscopic treatment of early-stage lung cancer.     Cancer Control 7 (1): 35-44, 2000

Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K. Localization of experimental submucosal
esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation. Lasers Surg Med 26
(1): 83-89, 2000

Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-
Mesochlorine e6 and adriamycin conjugates in combination treatments. Clin Cancer Res 6 (3): 1008-1015, 2000

Shutova T; Kriska T; Nemeth A; Agabekov V; Gal D. Physicochemical modeling of the role of free radicals in photodynamic therapy.
Biochem Biophys Res Commun 270 (1): 125-130, 2000

Sibata CH; Colussi VC; Oleinick NL; Kinsella TJ. Photodynamic therapy: a new concept in medical treatment.      Braz J Med Biol Res
33 (8): 869-880, 2000

Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES;
Lane AM; Birngruber R; van den BH; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM. A preliminary study of photodynamic
therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and
idiopathic causes. Arch Ophthalmol 118 (3): 327-336, 2000

Simkin GO; Tao JS; Levy JG; Hunt DW. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with
photodynamic therapy. J Immunol 164 (5): 2457-2462, 2000

Smetana K; Cajthamlova H; Grebenova D; Hrkal Z. The 5-aminolaevulinic acid-based photodynamic effects on nuclei and nucleoli of
HL-60 leukemic granulocytic precursors. J Photochem Photobiol B 59 (1-3): 80-86, 2000

Sokolov VS; Block M; Stozhkova IN; Pohl P. Membrane photopotential generation by interfacial differences in the turnover of a
photodynamic reaction. Biophys J 79 (4): 2121-2131, 2000

Soler AM; Warloe T; Tausjo J; Giercksky KE. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy
using topical 5-aminolevulinic acid or methylester aminolevulinic acid. Acta Oncol 39 (5): 605-609, 2000

Somjen GG. Enhancement of persistent sodium current by internal fluorescence in isolated hippocampal neurons. Brain Res 885 (1):
94-101, 2000

Songca SP; Mbatha B. Solubilization of meso-tetraphenylporphyrin photosensitizers by substitution with fluorine and with 2,3-
dihydroxy-1-propyloxy groups. J Pharm Pharmacol 52 (11): 1361-1367, 2000

Spinelli P; De Paoli F. [Photodynamic treatment of tumors]. Recenti Prog Med 91 (6): 310-313, 2000

Stanzel F; Haussinger K; Geiger D; Pichler J; Sauer W; Stepp H. [Photodynamic therapy in pneumology].       Pneumologie 54 (7): 269-
277, 2000

Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-
aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic
therapy. Eur J Dermatol 10 (5): 351-356, 2000



16
Stender IM; Na R; Fogh H; Gluud C; Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and
hand warts: randomised double-blind trial. Lancet 355 (9208): 963-966, 2000

Stief TW; Fareed J. The antithrombotic factor singlet oxygen/light (1O2/h nu).   Clin Appl Thromb Hemost 6 (1): 22-30, 2000

Stilts CE; Nelen MI; Hilmey DG; Davies SR; Gollnick SO; Oseroff AR; Gibson SL; Hilf R; Detty MR. Water-soluble, core-modified
porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. J Med Chem 43 (12): 2403-2410, 2000

Stranadko EF; Koraboev UM; Tolstykh MP. [Photodynamic therapy in suppurative diseases of soft tissues]. Khirurgiia (Mosk) (9):
67-70, 2000

Stummer W; Novotny A; Stepp H; Goetz C; Bise K; Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-
aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93 (6): 1003-1013, 2000

Suh HJ; Kim CS; Jung J. Cytochrome b6/f complex as an indigenous photodynamic generator of singlet oxygen in thylakoid membranes.
Photochem Photobiol 71 (1): 103-109, 2000

Swisher SG; Pisters PW; Komaki R; Lahoti S; Ajani JA. Gastroesophageal junction adenocarcinoma. Curr Treat Options Oncol 1 (5):
387-398, 2000

Szeimis M. [Success of photodynamic therapy in circumscribed scleroderma. Interview with PD Dr. M. Szeimis, Regensburg University
Dermatologic Clinic]. Hautarzt 51 (4): 296-297, 2000

Takeuchi K; Hanai H; Iida T; Suzuki S; Isobe S. A bleeding gastric ulcer on a vanishing tumor caused by anisakiasis.    Gastrointest
Endosc 52 (4): 549-551, 2000

Tamada K; Sugano K. Diagnosis and non-surgical treatment of bile duct carcinoma: developments in the past decade. J Gastroenterol
35 (5): 319-325, 2000

Tanielian C; Mechin R; Seghrouchni R; Schweitzer C. Mechanistic and kinetic aspects of photosensitization in the presence of oxygen.
Photochem Photobiol 71 (1): 12-19, 2000

Tannous M; Hutnik CM; Tingey DP; Mutus B. S-nitrosoglutathione photolysis as a novel therapy for antifibrosis in filtration surgery.
Invest Ophthalmol Vis Sci 41 (3): 749-755, 2000

Thanos S; Fischer D; Pavlidis M; Heiduschka P; Bodeutsch N. Glioanatomy assessed by cell-cell interactions and phagocytotic labelling.
J Neurosci Methods 103 (1): 39-50, 2000

Thissen MR; Schroeter CA; Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas
using a prior debulking technique. Br J Dermatol 142 (2): 338-339, 2000

Thunell S; Harper P; Brun A. Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protopo rphyria--
diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest 60 (7): 581-604, 2000

Tkachenko AV. Effect of bilirubin on the activity and thermokinetic characteristics of brain (synaptosomal) membrane NO synthase.
Membr Cell Biol 13 (3): 369-378, 2000

Toma HE. Supramolecular chemistry and technology. An Acad Bras Cienc 72 (1): 5-25, 2000

Tong Z; Singh G; Rainbow AJ. The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic
therapy. Photochem Photobiol 71 (2): 201-210, 2000

Trindade GS; Farias SL; Rumjanek VM; Capella MA. Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant
cells to this dye and its photodynamic action. Cancer Lett 151 (2): 161-167, 2000

Trivedi NS; Wang HW; Nieminen AL; Oleinick NL; Izatt JA. Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R)
cells via double-label confocal fluorescence microscopy. Photochem Photobiol 71 (5): 634-639, 2000

Tsoukas MM; Gonzalez S; Flotte TJ; Anderson RR; Sherwood ME; Kollias N. Wavelength and fluence effect on vascular damage with
photodynamic therapy on skin. J Invest Dermatol 114 (2): 303-308, 2000

Tsujino I; Sieber F. Genetic variability in the response of normal murine hematopoietic progenitor cells to extracorporeal
photochemotherapy. Photochem Photobiol 72 (6): 810-814, 2000


17
Uehara M; Sano K; Wang ZL; Sekine J; Ikeda H; Inokuchi T. Enhancement of the photodynamic antitumor effect by streptococcal
preparation OK-432 in the mouse carcinoma. Cancer Immunol Immunother 49 (8): 401-409, 2000

Uehlinger P; Zellweger M; Wagnieres G; Juillerat-Jeanneret L; van den BH; Lange N. 5-Aminolevulinic acid and its derivatives:
physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B 54 (1): 72-80, 2000

Uzdenskii AB; Zhavoronkova AA; Mironov AF; Kuz'min SG. [Study of the photodynamic effect of new photosensitizers on the sing le
neuron]. Izv Akad Nauk Ser Biol (2): 230-238, 2000

Uzdensky AB; Derkacheva VM; Dergacheva OY; Zhavoronkova AA. A single neuron response to photodynamic effect of various
aluminum and zinc phthalocyanines. Life Sci 68 (5): 547-555, 2000

Vaidyanathan VV; Rastegar S; Fossum TW; Flores P; Der Breggen EW; Egger NG; Jacques SL; Motamedi M. A study of
aminolevulinic acid-induced protoporphyrin IX fluorescence kinetics in the canine oral cavity. Lasers Surg Med 26 (4): 405-414, 2000

van den Akker JT; de Bruijn HS; Beijersbergen Van Henegouwen GM; Star WM; Sterenborg HJ. Protoporphyrin IX fluorescence
kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin
cancer. Photochem Photobiol 72 (3): 399-406, 2000

van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J. Topical application of 5-aminolevulinic acid hexyl ester and 5-
aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum
corneum. Photochem Photobiol 72 (5): 681-689, 2000

van den Besselaar AM; Moor AC. Photodynamic treatment of pooled coumarin plasma for external quality assessment of the
prothrombin time. J Clin Pathol 53 (6): 470-475, 2000

van den BJ; Van Staveren HJ; de Bruin RWF; de Rooij FWM; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R. Fractionated
illumination in oesophageal ALA-PDT: effect on ferrochelatase activity. J Photochem Photobiol B 56 (1): 53-60, 2000

van Tenten Y; Schuitmaker JJ; De G, V; Willekens B; Vrensen GF; Tassignon MJ. Cell biological mechanisms underlying posterior
capsule opacification: search for a therapy. Bull Soc Belge Ophtalmol (278): 61-66, 2000

Van Vugt DA; Krzemien A; Roy BN; Fletcher WA; Foster W; Lundahl S; Marcus SL; Reid RL. Photodynamic endometrial ablation in
the nonhuman primate. J Soc Gynecol Investig 7 (2): 125-130, 2000

vanSteveninck J; Trannoy LL; Besselink GA; Dubbelman TM; Brand A; de Korte D; Verhoeven AJ; Lagerberg JW. Selective protection
of RBCs against photodynamic damage by the band 3 ligand dipyridamole. Transfusion 40 (11): 1330-1336, 2000

Varma S; Holt PJ; Anstey AV. Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale.
Br J Dermatol 142 (4): 825-826, 2000

Verma L; Das T; Binder S; Heriot WJ; Kirchhof B; Venkatesh P; Krebs I; Stolba U; Jahn C; Feichtinger H; Kellner L; Krugluger H;
Pawelka I; Frohner U; Kruger A; Li W; Tewari HK. New approaches in the management of choroidal neovascular membrane in age-
related macular degeneration. Indian J Ophthalmol 48 (4): 263-278, 2000

Viola A; Lutz NW; Maroc C; Chabannon C; Julliard M; Cozzone PJ. Metabolic effects of photodynamically induced apoptosis in an
erythroleukemic cell line. A (31)P NMR spectroscopic study of Victoria-Blue-BO-sensitized TF-1 cells. Int J Cancer 85 (5): 733-739,
2000

Visona A; Angelini A; Gobbo S; Bonanome A; Thiene G; Pagnan A; Tonello D; Bonandini E; Jori G. Local photodynamic therapy with
Zn(II)-phthalocyanine in an experimental model of intimal hyperplasia. J Photochem Photobiol B 57 (2-3): 94-101, 2000

Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA. Targeting of a
hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy. Int J
Cancer 88 (1): 108-114, 2000

Vulcan TG; Zhu TC; Rodriguez CE; Hsi A; Fraker DL; Baas P; Murrer LH; Star WM; Glatstein E; Yodh AG; Hahn SM. Comparison
between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy. Lasers Surg Med 26 (3): 292-301,
2000

Wainwright M. Methylene blue derivatives--suitable photoantimicrobials for blood product disinfection? Int J Antimicrob Agents 16
(4): 381-394, 2000


18
Walther MM. The role of photodynamic therapy in the treatment of recurrent superficial bladder cancer.   Urol Clin North Am 27 (1):
163-170, 2000

Wang D; Bu F; Xu J. [Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma
proteins]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 14 (1): 52-55, 2000

Wang JM; Asami T; Murofushi N; Yoshida S. Isolation and initial characterization of 13(2)-hydroxychlorophyll a induced by
cyclohexanedione derivatives in tobacco cell suspension cultures. Photochem Photobiol 71 (1): 84-89, 2000

Wang KK; Nijhawan PK. Complications of photodynamic therapy in gastrointestinal disease.      Gastrointest Endosc Clin N Am 10 (3):
487-495, 2000

Wang KK. Photodynamic therapy of Barrett's esophagus. Gastrointest Endosc Clin N Am 10 (3): 409-419, 2000

Warren WH. Palliation of dysphagia.    Chest Surg Clin N Am 10 (3): 605-6xi, 2000

Watanabe Y. [Advances in diagnosis and treatment of lung cancer].   Nippon Rinsho 58 (5): 993-998, 2000

Webber J; Herman M; Kessel D; Fromm D. Photodynamic treatment of neoplastic lesions of the gastrointestinal tract. Recent advances
in techniques and results. Langenbecks Arch Surg 385 (4): 299-304, 2000

Weigel TL; Yousem S; Dacic S; Kosco PJ; Siegfried J; Luketich JD. Fluorescence bronchoscopic surveillance after curative surgical
resection for non-small-cell lung cancer. Ann Surg Oncol 7 (3): 176-180, 2000

Weizman E; Rothmann C; Greenbaum L; Shainberg A; Adamek M; Ehrenberg B; Malik Z. Mitochondrial localization and photodamage
during photodynamic therapy with tetraphenylporphines. J Photochem Photobiol B 59 (1-3): 92-102, 2000

Wennberg AM. Basal cell carcinoma--new aspects of diagnosis and treatment. Acta Derm Venereol Suppl (Stockh) 209: 5-25, 2000

Wennberg AM; Larko O; Lonnroth P; Larson G; Krogstad AL. Delta-aminolevulinic acid in superficial basal cell carcinomas and normal
skin-a microdialysis and perfusion study. Clin Exp Dermatol 25 (4): 317-322, 2000

Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL. Photodynamic therapy with the
phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin Cancer Res 6 (5): 2021-2027,
2000

Williams PB; Crouch ER, Jr.; Sheppard JD, Jr.; Lattanzio FA, Jr.; Parker TA; Mitrev PV. The birth of ocular pharmacology in the 20th
century. J Clin Pharmacol 40 (9): 990-1006, 2000

Wolfsen HC. Photodynamic therapy in gastroenterology: current status in the year 2000.   Endoscopy 32 (9): 715-719, 2000

Wormald R; Evans J; Smeeth L. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev
(2): CD002030, 2000

Wu T; Xu S; Shen J; Song A; Chen S; Zhang M; Shen T. New potential photodynamic therapeutic anti-cancer agents: synthesis and
characterization of demethoxy amino-substituted hypocrellins. Anticancer Drug Des 15 (4): 287-293, 2000

Wu T; Shen J; Song A; Chen S; Zhang M; Shen T. Photodynamic action of amino substituted hypocrellins: EPR studies on the
photogenerations of active oxygen and free radical species. J Photochem Photobiol B 57 (1): 14-21, 2000

Yamaguchi A; Woodburn KW; Hayase M; Robbins RC. Reduction of vein graft disease using photodynamic therapy with motexafin
lutetium in a rodent isograft model. Circulation 102 (19 Suppl 3): III275-III280, 2000

Yang SM; Doi T; Asako M; Matsumoto A; Yamashita T. Optical recording of membrane potential in dissociated mouse vestibular
ganglion cells using a voltage-sensitive dye. Auris Nasus Larynx 27 (1): 15-21, 2000

Yang Y; Lu C; Zhao J; Wu Y; Cao G. [Optimal treatment parameters for damage of chicken comb vessels using chlorophyll derivative
IV in photodynamic therapy]. Hua Xi Kou Qiang Yi Xue Za Zhi 18 (3): 159-162, 2000

Yassur Y; Weinberger D; Goldstein M; Loewenstein A. [Photodynamic therapy in age-related macular degeneration]. Harefuah 139
(5-6): 220-223, 2000




19
Yokota T; Ikeda H; Inokuchi T; Sano K; Koji T. Enhanced cell death in NR-S1 tumor by photodynamic therapy: possible involvement of
Fas and Fas ligand system. Lasers Surg Med 26 (5): 449-460, 2000

Yow CM; Chen JY; Mak NK; Cheung NH; Leung AW. Cellular uptake, subcellular localization and photodamaging effect of temoporfin
(mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative. Cancer Lett 157 (2): 123-131, 2000

Yow CM; Mak NK; Szeto S; Chen JY; Lee YL; Cheung NH; Huang DP; Leung AW. Photocytotoxic and DNA damaging effect of
temoporfin (mTHPC) and merocyanine 540 (MC540) on nasopharyngeal carcinoma cell. Toxicol Lett 115 (1): 53-61, 2000

Yslas I; Alvarez MG; Marty C; Mori G; Durantini EN; Rivarola V. Expression of Fas antigen and apoptosis caused by 5,10,15, 20-
tetra(4-methoxyphenyl)porphyrin (TMP) on carcinoma cells: implication for photodynamic therapy. Toxicology 149 (2-3): 69-74,
2000

Zargi M; Fajdiga I; Smid L. Autofluorescence imaging in the diagnosis of laryngeal cancer. Eur Arch Otorhinolaryngol 257 (1): 17-
23, 2000

Zhang SP; Zhao JQ; Jiang LJ. Photosensitized formation of singlet oxygen by phycobiliproteins in neutral aqueous solutions.   Free
Radic Res 33 (5): 489-496, 2000

Zhao Y; Yang B; Zhang T; Cai L; Zhu Y. [Photodynamic therapy of hematoporphyrin derivative on human pancreatic carcinoma cell
lines]. Zhonghua Wai Ke Za Zhi 38 (3): 204-207, 2000

Zheng G; Potter WR; Sumlin A; Dougherty TJ; Pandey RK. Photosensitizers related to purpurin-18-N-alkylimides: a comparative in
vivo tumoricidal ability of ester versus amide functionalities. Bioorg Med Chem Lett 10 (2): 123-127, 2000

Zheng G; Shibata M; Dougherty TJ; Pandey RK. Wittig reactions on photoprotoporphyrin IX: new synthetic models for the special pair
of the photosynthetic reaction center. J Org Chem 65 (2): 543-557, 2000

Zhou GY; Zhang ZY; Gu JZ; Ma JZ. [Comparative research on mixed and 488 nm argon laser PDT for port wine stain].        Shanghai Kou
Qiang Yi Xue 9 (3): 173-174, 2000

Zhou GY; Zhang ZY. [Preliminary clinical study on krypton laser photodynamic therapy for PWS].      Shanghai Kou Qiang Yi Xue 9
(3): 168-170, 2000

Zollo JD; Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget's disease.     Br J Dermatol 142 (1): 59-
65, 2000

Zopf T; Riemann JF. [Therapy of pancreatic and bile duct tumors: value of radiotherapy and photodynamic therapy].    Schweiz Rundsch
Med Prax 89 (33): 1293-1298, 2000

Zorin VP; Khludeev II; Zorina TE. [Distribution of porphyrin sensitizers among protein and cellular blood elements]. Biofizika 45 (2):
313-319, 2000




20

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:33
posted:2/18/2010
language:English
pages:20